Global Spinal Cord Stimulation (Scs) Devices
Global Spinal Cord Stimulation (Scs) Devices

Spinal Cord Stimulation (Scs) Devices Comprehensive Study by Type (Conventional implantable pulse generator (IPG), Rechargeable IPG, Radiofrequency stimulator), Application (Back Pain, Post-Surgical Pain, Arachnoiditis, Heart Pain (Angina)), End User (Hospitals, Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2027

Spinal Cord Stimulation (Scs) Devices Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

May 2022 Edition 233 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Spinal Cord Stimulation (Scs) Devices Market Overview:
Spinal cord stimulation has become a popular and effective treatment option for refractory chronic pain that has not responded to conventional therapies. Technological advancements have been significant, and current neuromodulation devices have both been extremely advanced and efficient in producing good results for a variety of clinical situations of chronic pain, including failed back surgery syndrome, complex regional pain syndrome, ischemic and coronary artery disease. Despite its high initial price, this technique is likely to save money compared to different therapy strategies. Spinal cord stimulation remains an effective treatment option for chronic, disabling pain.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies ProfiledJohnson & Johnson (United States), Abbott (United States), Roche (United States), Merck & Co. (United States), GlaxoSmithKline (United Kingdom), Boston Scientific (United States), Medtronic (United States), Stimwave (United States) and Nevro (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • Rising Prevalence Of Chronic Pain Among Adults
  • Rising Number Of Patients Suffering From Spinal Cord Stimulation

Roadblocks
  • Availability Of Alternative Treatment Methods
  • High Cost Of Spinal Cord Stimulation

Opportunities
  • Technological Advancement In The Healthcare Industry
  • Increasing Incidence Of The Failed Back Syndrome
  • Availability Of Medical Reimbursements

Challenges
  • Lack Of Trained Professional


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Johnson & Johnson (United States), Abbott (United States), Roche (United States), Merck & Co. (United States), GlaxoSmithKline (United Kingdom), Boston Scientific (United States), Medtronic (United States), Stimwave (United States) and Nevro (United States). Additionally, following companies can also be profiled that are part of our coverage like Cirtec (United States) and Nuvectra (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Spinal Cord Stimulation (Scs) Devices market by 2027. Considering Market by , the sub-segment i.e. will boost the Spinal Cord Stimulation (Scs) Devices market.

On 10 September 2021, Boston Scientific has announced the European launch of FAST a new, fast-acting sub-perception therapy that the company says is clinically proven to demonstrate significant and sustained pain relief within minutes for its WaveWriter Alpha spinal cord stimulator (SCS) systems.

What Can be Explored with the Spinal Cord Stimulation (Scs) Devices Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Spinal Cord Stimulation (Scs) Devices Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Spinal Cord Stimulation (Scs) Devices
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Spinal Cord Stimulation (Scs) Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Spinal Cord Stimulation (Scs) Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. Who are the top performing companies in Spinal Cord Stimulation (Scs) Devices Market?
Top performing companies in the Global Spinal Cord Stimulation (Scs) Devices market are Johnson & Johnson (United States), Abbott (United States), Roche (United States), Merck & Co. (United States), GlaxoSmithKline (United Kingdom), Boston Scientific (United States), Medtronic (United States), Stimwave (United States) and Nevro (United States), to name a few.

2. What trending factors would impact Spinal Cord Stimulation (Scs) Devices Market growth most?
"Growing Healthcare Infrastructure In The Developing Economies" is seen as one of major influencing trends for Spinal Cord Stimulation (Scs) Devices Market during projected period 2021-2027.

Report Objectives / Segmentation Covered
By Type
  • Conventional implantable pulse generator (IPG)
  • Rechargeable IPG
  • Radiofrequency stimulator
By Application
  • Back Pain
  • Post-Surgical Pain
  • Arachnoiditis
  • Heart Pain (Angina)
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence Of Chronic Pain Among Adults
      • 3.2.2. Rising Number Of Patients Suffering From Spinal Cord Stimulation
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Trained Professional
    • 3.4. Market Trends
      • 3.4.1. Growing Healthcare Infrastructure In The Developing Economies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Spinal Cord Stimulation (Scs) Devices, by Type, Application, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Spinal Cord Stimulation (Scs) Devices (Value)
      • 5.2.1. Global Spinal Cord Stimulation (Scs) Devices by: Type (Value)
        • 5.2.1.1. Conventional implantable pulse generator (IPG)
        • 5.2.1.2. Rechargeable IPG
        • 5.2.1.3. Radiofrequency stimulator
      • 5.2.2. Global Spinal Cord Stimulation (Scs) Devices by: Application (Value)
        • 5.2.2.1. Back Pain
        • 5.2.2.2. Post-Surgical Pain
        • 5.2.2.3. Arachnoiditis
        • 5.2.2.4. Heart Pain (Angina)
      • 5.2.3. Global Spinal Cord Stimulation (Scs) Devices by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Ambulatory Surgical Centers
      • 5.2.4. Global Spinal Cord Stimulation (Scs) Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Spinal Cord Stimulation (Scs) Devices (Price)
      • 5.3.1. Global Spinal Cord Stimulation (Scs) Devices by: Type (Price)
  • 6. Spinal Cord Stimulation (Scs) Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GlaxoSmithKline (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boston Scientific (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medtronic (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Stimwave (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nevro (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Spinal Cord Stimulation (Scs) Devices Sale, by Type, Application, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Spinal Cord Stimulation (Scs) Devices (Value)
      • 7.2.1. Global Spinal Cord Stimulation (Scs) Devices by: Type (Value)
        • 7.2.1.1. Conventional implantable pulse generator (IPG)
        • 7.2.1.2. Rechargeable IPG
        • 7.2.1.3. Radiofrequency stimulator
      • 7.2.2. Global Spinal Cord Stimulation (Scs) Devices by: Application (Value)
        • 7.2.2.1. Back Pain
        • 7.2.2.2. Post-Surgical Pain
        • 7.2.2.3. Arachnoiditis
        • 7.2.2.4. Heart Pain (Angina)
      • 7.2.3. Global Spinal Cord Stimulation (Scs) Devices by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Ambulatory Surgical Centers
      • 7.2.4. Global Spinal Cord Stimulation (Scs) Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Spinal Cord Stimulation (Scs) Devices (Price)
      • 7.3.1. Global Spinal Cord Stimulation (Scs) Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Spinal Cord Stimulation (Scs) Devices: by Type(USD Million)
  • Table 2. Spinal Cord Stimulation (Scs) Devices Conventional implantable pulse generator (IPG) , by Region USD Million (2016-2021)
  • Table 3. Spinal Cord Stimulation (Scs) Devices Rechargeable IPG , by Region USD Million (2016-2021)
  • Table 4. Spinal Cord Stimulation (Scs) Devices Radiofrequency stimulator , by Region USD Million (2016-2021)
  • Table 5. Spinal Cord Stimulation (Scs) Devices: by Application(USD Million)
  • Table 6. Spinal Cord Stimulation (Scs) Devices Back Pain , by Region USD Million (2016-2021)
  • Table 7. Spinal Cord Stimulation (Scs) Devices Post-Surgical Pain , by Region USD Million (2016-2021)
  • Table 8. Spinal Cord Stimulation (Scs) Devices Arachnoiditis , by Region USD Million (2016-2021)
  • Table 9. Spinal Cord Stimulation (Scs) Devices Heart Pain (Angina) , by Region USD Million (2016-2021)
  • Table 10. Spinal Cord Stimulation (Scs) Devices: by End User(USD Million)
  • Table 11. Spinal Cord Stimulation (Scs) Devices Hospitals , by Region USD Million (2016-2021)
  • Table 12. Spinal Cord Stimulation (Scs) Devices Clinics , by Region USD Million (2016-2021)
  • Table 13. Spinal Cord Stimulation (Scs) Devices Ambulatory Surgical Centers , by Region USD Million (2016-2021)
  • Table 14. South America Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2016-2021)
  • Table 15. South America Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 16. South America Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 17. South America Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 18. Brazil Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 19. Brazil Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 20. Brazil Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 21. Argentina Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 22. Argentina Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 23. Argentina Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 24. Rest of South America Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 25. Rest of South America Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 26. Rest of South America Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 27. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2016-2021)
  • Table 28. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 29. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 30. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 31. China Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 32. China Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 33. China Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 34. Japan Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 35. Japan Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 36. Japan Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 37. India Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 38. India Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 39. India Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 40. South Korea Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 41. South Korea Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 42. South Korea Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 43. Taiwan Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 44. Taiwan Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 45. Taiwan Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 46. Australia Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 47. Australia Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 48. Australia Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 52. Europe Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2016-2021)
  • Table 53. Europe Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 54. Europe Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 55. Europe Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 56. Germany Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 57. Germany Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 58. Germany Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 59. France Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 60. France Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 61. France Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 62. Italy Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 63. Italy Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 64. Italy Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 65. United Kingdom Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 66. United Kingdom Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 67. United Kingdom Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 68. Netherlands Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 69. Netherlands Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 70. Netherlands Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 71. Rest of Europe Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 72. Rest of Europe Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 73. Rest of Europe Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 74. MEA Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2016-2021)
  • Table 75. MEA Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 76. MEA Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 77. MEA Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 78. Middle East Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 79. Middle East Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 80. Middle East Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 81. Africa Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 82. Africa Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 83. Africa Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 84. North America Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2016-2021)
  • Table 85. North America Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 86. North America Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 87. North America Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 88. United States Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 89. United States Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 90. United States Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 91. Canada Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 92. Canada Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 93. Canada Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 94. Mexico Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2016-2021)
  • Table 95. Mexico Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2016-2021)
  • Table 96. Mexico Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2016-2021)
  • Table 97. Spinal Cord Stimulation (Scs) Devices: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Spinal Cord Stimulation (Scs) Devices: by Type(USD Million)
  • Table 108. Spinal Cord Stimulation (Scs) Devices Conventional implantable pulse generator (IPG) , by Region USD Million (2022-2027)
  • Table 109. Spinal Cord Stimulation (Scs) Devices Rechargeable IPG , by Region USD Million (2022-2027)
  • Table 110. Spinal Cord Stimulation (Scs) Devices Radiofrequency stimulator , by Region USD Million (2022-2027)
  • Table 111. Spinal Cord Stimulation (Scs) Devices: by Application(USD Million)
  • Table 112. Spinal Cord Stimulation (Scs) Devices Back Pain , by Region USD Million (2022-2027)
  • Table 113. Spinal Cord Stimulation (Scs) Devices Post-Surgical Pain , by Region USD Million (2022-2027)
  • Table 114. Spinal Cord Stimulation (Scs) Devices Arachnoiditis , by Region USD Million (2022-2027)
  • Table 115. Spinal Cord Stimulation (Scs) Devices Heart Pain (Angina) , by Region USD Million (2022-2027)
  • Table 116. Spinal Cord Stimulation (Scs) Devices: by End User(USD Million)
  • Table 117. Spinal Cord Stimulation (Scs) Devices Hospitals , by Region USD Million (2022-2027)
  • Table 118. Spinal Cord Stimulation (Scs) Devices Clinics , by Region USD Million (2022-2027)
  • Table 119. Spinal Cord Stimulation (Scs) Devices Ambulatory Surgical Centers , by Region USD Million (2022-2027)
  • Table 120. South America Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2022-2027)
  • Table 121. South America Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 122. South America Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 123. South America Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 124. Brazil Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 125. Brazil Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 126. Brazil Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 127. Argentina Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 128. Argentina Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 129. Argentina Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 130. Rest of South America Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 131. Rest of South America Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 132. Rest of South America Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 133. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2022-2027)
  • Table 134. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 135. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 136. Asia Pacific Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 137. China Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 138. China Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 139. China Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 140. Japan Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 141. Japan Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 142. Japan Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 143. India Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 144. India Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 145. India Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 146. South Korea Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 147. South Korea Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 148. South Korea Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 149. Taiwan Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 150. Taiwan Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 151. Taiwan Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 152. Australia Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 153. Australia Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 154. Australia Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 155. Rest of Asia-Pacific Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 156. Rest of Asia-Pacific Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 157. Rest of Asia-Pacific Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 158. Europe Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2022-2027)
  • Table 159. Europe Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 160. Europe Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 161. Europe Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 162. Germany Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 163. Germany Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 164. Germany Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 165. France Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 166. France Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 167. France Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 168. Italy Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 169. Italy Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 170. Italy Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 171. United Kingdom Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 172. United Kingdom Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 173. United Kingdom Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 174. Netherlands Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 175. Netherlands Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 176. Netherlands Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 177. Rest of Europe Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 178. Rest of Europe Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 179. Rest of Europe Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 180. MEA Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2022-2027)
  • Table 181. MEA Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 182. MEA Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 183. MEA Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 184. Middle East Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 185. Middle East Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 186. Middle East Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 187. Africa Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 188. Africa Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 189. Africa Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 190. North America Spinal Cord Stimulation (Scs) Devices, by Country USD Million (2022-2027)
  • Table 191. North America Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 192. North America Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 193. North America Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 194. United States Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 195. United States Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 196. United States Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 197. Canada Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 198. Canada Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 199. Canada Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 200. Mexico Spinal Cord Stimulation (Scs) Devices, by Type USD Million (2022-2027)
  • Table 201. Mexico Spinal Cord Stimulation (Scs) Devices, by Application USD Million (2022-2027)
  • Table 202. Mexico Spinal Cord Stimulation (Scs) Devices, by End User USD Million (2022-2027)
  • Table 203. Spinal Cord Stimulation (Scs) Devices: by Type(USD/Units)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Spinal Cord Stimulation (Scs) Devices: by Type USD Million (2016-2021)
  • Figure 5. Global Spinal Cord Stimulation (Scs) Devices: by Application USD Million (2016-2021)
  • Figure 6. Global Spinal Cord Stimulation (Scs) Devices: by End User USD Million (2016-2021)
  • Figure 7. South America Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 8. Asia Pacific Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 9. Europe Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 10. MEA Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 11. North America Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 12. Global Spinal Cord Stimulation (Scs) Devices: by Type USD/Units (2016-2021)
  • Figure 13. Global Spinal Cord Stimulation (Scs) Devices share by Players 2021 (%)
  • Figure 14. Global Spinal Cord Stimulation (Scs) Devices share by Players (Top 3) 2021(%)
  • Figure 15. Global Spinal Cord Stimulation (Scs) Devices share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 19. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott (United States) Revenue: by Geography 2021
  • Figure 21. Roche (United States) Revenue, Net Income and Gross profit
  • Figure 22. Roche (United States) Revenue: by Geography 2021
  • Figure 23. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Merck & Co. (United States) Revenue: by Geography 2021
  • Figure 25. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2021
  • Figure 27. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Boston Scientific (United States) Revenue: by Geography 2021
  • Figure 29. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (United States) Revenue: by Geography 2021
  • Figure 31. Stimwave (United States) Revenue, Net Income and Gross profit
  • Figure 32. Stimwave (United States) Revenue: by Geography 2021
  • Figure 33. Nevro (United States) Revenue, Net Income and Gross profit
  • Figure 34. Nevro (United States) Revenue: by Geography 2021
  • Figure 35. Global Spinal Cord Stimulation (Scs) Devices: by Type USD Million (2022-2027)
  • Figure 36. Global Spinal Cord Stimulation (Scs) Devices: by Application USD Million (2022-2027)
  • Figure 37. Global Spinal Cord Stimulation (Scs) Devices: by End User USD Million (2022-2027)
  • Figure 38. South America Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 39. Asia Pacific Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 40. Europe Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 41. MEA Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 42. North America Spinal Cord Stimulation (Scs) Devices Share (%), by Country
  • Figure 43. Global Spinal Cord Stimulation (Scs) Devices: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • Johnson & Johnson (United States)
  • Abbott (United States)
  • Roche (United States)
  • Merck & Co. (United States)
  • GlaxoSmithKline (United Kingdom)
  • Boston Scientific (United States)
  • Medtronic (United States)
  • Stimwave (United States)
  • Nevro (United States)
Additional players considered in the study are as follows:
Cirtec (United States) , Nuvectra (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation